Lv1
80 积分 2022-02-15 加入
Response and Resistance to RAS Inhibition in Cancer
1个月前
已完结
Screening approaches for kinases
2个月前
已关闭
HER2 heterogeneous breast cancer models reveal novel therapeutic targets and subclonal dynamics during evolution to resistance to HER2-targeted therapies
3个月前
已完结
Screening approaches for kinases
3个月前
已关闭
Direct Inhibition of RAS Reveals the Features of Oncogenic Signaling Driven by RAS G12 and Q61 Mutations
3个月前
已完结
P3.12.26 Adding Gefitinib to Target Acquired C797S Mutation After Progression on First-Line Osimertinib in EGFR-Mutant Advanced NSCLC
4个月前
已关闭
Challenges and opportunities of emerging mechanisms of resistance to KRASG12C inhibitors
4个月前
已完结
A Comprehensive Review of Marketed KRAS Inhibitors and Degraders: Challenges and Opportunities
4个月前
已完结
Metabolism of Strained Rings: Glutathione S-transferase–Catalyzed Formation of a Glutathione-Conjugated Spiro-azetidine without Prior Bioactivation
5个月前
已完结
High Throughput Screening Assessment of Reactive Oxygen Species (ROS) Generation using Dihydroethidium (DHE) Fluorescence Dye
5个月前
已完结
皖公网安备34019202002308
